Editorials

Improving child survival through vitamin A supplementation

BMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d5294 (Published 25 August 2011) Cite this as: BMJ 2011;343:d5294
  1. Andrew Thorne-Lyman, doctoral candidate1,
  2. Wafaie W Fawzi, professor2
  1. 1Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
  2. 2Departments of Nutrition, Epidemiology, and Global Health, Harvard School of Public Health
  1. mina{at}hsph.harvard.edu

Fine tuning the dose and delivery mechanism could further improve outcomes

Worldwide, nearly 8.8 million children die each year before they reach their 5th birthday.1 More than two thirds die from infectious diseases such as pneumonia, diarrhoea, and malaria. Although these are sobering figures, childhood mortality has been substantially reduced over the past decade partly as a result of the expansion of child survival interventions to prevent and treat major causes of childhood mortality.

In the linked systematic review and meta-analysis (doi:10.1136/bmj.d5094), Mayo-Wilson and colleagues assess the effects of vitamin A supplementation on mortality and morbidity in children 6 months to 5 years of age.2 Routine preventive treatment of all children 6-59 months of age with high dose vitamin A supplements is a core intervention to improve child survival supported by Unicef, the World Health Organization, governments, and donors in areas of high mortality and endemic vitamin A deficiency. Capsules are now distributed biannually in at least 60 countries, with average annual coverage rates nearing 80%.3 Initially launched as an initiative to prevent xerophthalmic blindness, universal vitamin A supplementation was expanded as a life saving intervention mainly on the basis of meta-analyses that showed average reductions in …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe